Potential Merger of Two of the Nation's Largest Pharmacy Benefit Companies May Produce Conflict of Interest
source: http://nyti.ms/tcD6XG
The New York Times: http://nyti.ms/tcD6XG
From the article:
"In the area of specialty drugs, which are increasingly contributing to higher costs, benefit managers are able to profit from the difference between what employers and insurers pay for these expensive drugs and the cost. The combined company would control almost a third of the market, according to one analysis. Robert Seidman, a former pharmacy executive at WellPoint who is now a health care consultant in Los Angeles, said the merger could result in a conflict of interest in the way that the pharmacy benefit manager makes money. “We’re not talking pennies here,” he said. “We’re talking thousands” per drug."
From the article:
"In the area of specialty drugs, which are increasingly contributing to higher costs, benefit managers are able to profit from the difference between what employers and insurers pay for these expensive drugs and the cost. The combined company would control almost a third of the market, according to one analysis. Robert Seidman, a former pharmacy executive at WellPoint who is now a health care consultant in Los Angeles, said the merger could result in a conflict of interest in the way that the pharmacy benefit manager makes money. “We’re not talking pennies here,” he said. “We’re talking thousands” per drug."
-
- groups:
- Community
-
- tags:
- Healthcare, Corporations, pharmacy, Merger, 6 more
